Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cybin Inc
CYBN
Primary Symbol:
N.CYBN
Healthcare
Drug Manufacturers - Specialty & Generic
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary...
deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NEO:CYBN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(933)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jun 21, 2021 8:37am
News: presenting at investment conference….
News here: https://stockhouse.com/news/press-releases/2021/06/21/ceo-presenting-on-the-first-emerging-growth-investors-hub-joint-conference-on
(933)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jun 17, 2021 8:09am
News: some scientific stuff about a molecule….
News here: https://www.businesswire.com/news/home/20210616005144/en/
(933)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jun 08, 2021 9:39am
News: Sponsors new Covid burnout study…..
News here: https://www.businesswire.com/news/home/20210608005236/en/
(933)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jun 01, 2021 11:13am
News: Sponsors new study on brain effects....
News here: https://www.businesswire.com/news/home/20210601005268/en/
(55)
•••
Poweraaa
X
View Profile
View Bullboard History
Post by
Poweraaa
on May 31, 2021 10:50am
Cybin to be included U.S.-listed ETF focused on Psychedelics
$CLXPF included in the first U.S.-listed ETF focused on Psychedelics under ticker $PSY https://prn.to/2Rbz2u2 #psilocybin $CMPS $MNMD
(55)
•••
Poweraaa
X
View Profile
View Bullboard History
Post by
Poweraaa
on May 28, 2021 4:32pm
We got Iron Mike, who is a change man because of this...
We got the Champ rooting for this medicine. https://cnalifestyle.channelnewsasia.com/lifestyle/mike-tyson-says-psychedelics-saved-his-life--now-he-hopes-they-can-change-the-world-14905650 Food
...more
(933)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on May 26, 2021 10:05am
News: International patent filed....
News here: https://www.businesswire.com/news/home/20210526005127/en/
(55)
•••
Poweraaa
X
View Profile
View Bullboard History
Comment by
Poweraaa
on May 20, 2021 3:11pm
RE:News: Phase II trials approved....
This is good news since, CMPS is only in Phase IIb
(933)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on May 20, 2021 9:31am
News: New patent filed....
News here: https://www.businesswire.com/news/home/20210520005334/en/
(933)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on May 18, 2021 9:27am
News: Phase II trials approved....
News here: https://stockhouse.com/news/press-releases/2021/05/18/cybin-granted-irb-approval-for-phase-ii-clinical-trials-of-its-sublingual
(0)
•••
hgdcybn
X
View Profile
View Bullboard History
Post by
hgdcybn
on Apr 29, 2021 11:18am
Sharing this post from The Motley Fool on Cybin
Forget Sundial Growers: Put This Stock on Your Radar
(4)
•••
Catmando123
X
View Profile
View Bullboard History
Post by
Catmando123
on Apr 28, 2021 3:37pm
Q1 Earnings Release _ HOLL
Expecting a 2-% pop by Friday - please feel free to do your own DD
(0)
•••
hgdcybn
X
View Profile
View Bullboard History
Post by
hgdcybn
on Apr 28, 2021 2:51pm
Great volume on the stock today
Great volume on the stock today. Over 7 million shares traded already.
(0)
•••
hgdcybn
X
View Profile
View Bullboard History
Post by
hgdcybn
on Apr 28, 2021 1:10pm
US$10 per share price target from Roth Capital for Cybin
just sharing this US$10 per share price target from Roth Capital on Cybin. This along side MMED Nasdaq listing is great for the industry. https://drive.google.com/file/d/17ehc
...more
(0)
•••
TrojanHorse82
X
View Profile
View Bullboard History
Post by
TrojanHorse82
on Mar 29, 2021 12:36am
Breakthrough Tech to Measure Real-Time Brain Activity
Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently announced its collaboration with neurotech
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test